Similar articles

• Mutant p53 subverts PLK2 function in a novel, reinforced loop of corruption.

  Haupt S, Haupt Y. Haupt S, et al. Cell Cycle. 2012 Jan 15;11(2):217-8. doi: 10.4161/cc.11.2.18977. Epub 2012 Jan 15. Cell Cycle. 2012. PMID: 22214663 No abstract available.
• Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop.

  Valenti F, Fausti F, Biagioni F, Shay T, Fontemaggi G, Domany E, Yaffe MB, Strano S, Blandino G, Di Agostino S. Valenti F, et al. Cell Cycle. 2011 Dec 15;10(24):4330-40. doi: 10.4161/cc.10.24.18682. Epub 2011 Dec 15. Cell Cycle. 2011. PMID: 22134238
• Chk2 meets Plk3 in damage control.

  Herzog CR. Herzog CR. Cell Cycle. 2002 Nov-Dec;1(6):408-9. doi: 10.4161/cc.1.6.268. Cell Cycle. 2002. PMID: 12548016 Review. No abstract available.
• The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR.

  Park BJ, Kang JW, Lee SW, Choi SJ, Shin YK, Ahn YH, Choi YH, Choi D, Lee KS, Kim S. Park BJ, et al. Cell. 2005 Jan 28;120(2):209-21. doi: 10.1016/j.cell.2004.11.054. Cell. 2005. PMID: 15680327
• Degradation of a non-cycling mammalian polo-like kinase.

  Dai W. Dai W. Cell Cycle. 2004 May;3(5):625-6. doi: 10.4161/cc.3.5.871. Epub 2004 May 19. Cell Cycle. 2004. PMID: 15107610 Review. No abstract available.